Today: 9 June 2026
Norwegian Cruise Line Gains 9% as Oil Drops, Fuel Still in Focus
20 May 2026
2 mins read

Norwegian Cruise Line Gains 9% as Oil Drops, Fuel Still in Focus

NEW YORK, May 20, 2026, 15:05 EDT

Norwegian Cruise Line Holdings shares climbed Wednesday afternoon, bouncing after four days of losses. Oil prices were down and cruise stocks attracted some buying in a travel sector that has been lagging.

NCLH was last at $16.15, higher by 9.2%, according to delayed quotes from 2:50 p.m. EDT. Carnival shares moved up 10.2%. Royal Caribbean picked up 2.6%. The SPDR S&P 500 ETF Trust, which tracks the U.S. benchmark, added 0.9%.

Norwegian shares closed at $14.79 on Tuesday, down 3.1%. That was the fourth drop in a row and put the stock about 46% under its 52-week high. With crude prices moving down and risk appetite picking up, the beaten-down stock had some room to bounce.

Oil prices sank, with Brent crude down almost 6% after President Donald Trump said U.S.-Iran talks were in the “final stages.” But Again Capital’s John Kilduff told Reuters investors should take Trump’s comments “with a grain of salt.” Cruise operators benefit when oil drops, since fuel accounts for a major expense and falling energy costs have a direct impact on margins. Reuters

Director Jose E. Cil picked up 15,000 shares of Norwegian through a family trust on May 18 and May 19, paying $15.25 and $14.91, according to a Form 4 filed with the SEC. The insider bought shares on the open market, not as a compensation award.

Norwegian’s rally held up, even as Wall Street got more cautious again. UBS dropped its price target to $17 from $22 on May 19 and kept a Neutral call, per MarketScreener. That target is just above where shares traded on Wednesday, showing analysts are treating the gains more as a challenge than a reset.

Norwegian detailed fresh guidance on May 4, cutting its 2026 adjusted earnings outlook to a range of $1.45 to $1.79 a share. The company said it now expects full-year net yield to drop 3% to 5% on a constant-currency basis. Adjusted EBITDA is now pegged at $2.48 billion to $2.64 billion. CEO John W. Chidsey said Norwegian “acted with urgency,” and CFO Mark Kempa cited “better-than-expected cost performance.” Norwegian Cruise Line Holdings Ltd.

Norwegian has been looking for ways to cut costs after it lost ground to rivals. In February, Elliott Management revealed a stake of over 10% and called for changes to the board and management. Truist Securities analyst Patrick Scholes told Reuters at the time that Norwegian’s issues aren’t a “quick fix” and “cannot be corrected overnight.” Reuters

Peer read-throughs had mixed reactions but brought some value. Last month, Royal Caribbean said Mediterranean bookings bounced back after earlier disruption, although the cruise operator cut profit guidance due to higher fuel. CFRA analyst Alex Fasciano told Reuters “sustained higher fuel costs” would weigh on the bottom line, but Royal Caribbean might change up itineraries to limit the impact. Reuters

Demand isn’t the only issue. The Associated Press said this week that cruise demand is holding up, even after recent health stories. The AP quoted Cornell’s Rob Kwortnik describing cruise consumers as “somewhat Teflon.” The outlet also pointed to an industry projection calling for a record 38.3 million ocean cruise passengers this year. AP News

But the setup can turn fast. Norwegian says it’s still short of its target booking range after some execution errors and Middle East uncertainty hit Europe, with $15.2 billion in total debt and net leverage at 5.3 times at March’s end. If oil climbs, Iran talks stall, or late European demand slips, Wednesday’s rally could end up just another squeeze in a low-priced stock, not the start of a real rebound.

Stock Market Today

  • Factorial Energy Shares Surge After Nasdaq Ticker Change from Cartesian Growth
    June 9, 2026, 9:18 AM EDT. Factorial Energy (ticker FAC) began trading on Nasdaq after merging with Cartesian Growth Corporation III (CGCT), marking the SPAC's transition from a shell company to an operating battery tech firm. Shares surged 16% to $13.80 on June 8, with premarket quotes near $20.70 the next day. The merger valued Factorial at approximately $1.3 billion and raised over $100 million to support commercializing solid-state batteries, which offer improved range and safety over traditional lithium-ion cells. CEO Siyu Huang emphasized the listing will accelerate the company's development. Factorial focuses on validation milestones, with partnerships including Mercedes-Benz and Stellantis. The move positions Factorial alongside public battery tech firms like QuantumScape and Solid Power, amid investor reshuffling following the transaction.

Latest articles

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

9 June 2026
Snap Inc. shares fell 1.9% to $5.65, underperforming a rising Nasdaq and leaving the stock 46% below its 52-week high, as investors weigh weak ad revenue growth, North American user declines, and cost-cutting moves against ongoing competitive pressure from Meta and TikTok.
Navitas Stock Is Surging Again—The AI Power-Chip Bet Now Has to Prove It Can Sell
Previous Story

Navitas Stock Is Surging Again—The AI Power-Chip Bet Now Has to Prove It Can Sell

Dow Jones Rises Past 50,000 Again After Closing Bell
Next Story

Dow Jones Rises Past 50,000 Again After Closing Bell

Go toTop